Impact of WHO guidelines on trends in HIV testing and ART initiation among children living with HIV in Zambia.


Journal

AIDS research and therapy
ISSN: 1742-6405
Titre abrégé: AIDS Res Ther
Pays: England
ID NLM: 101237921

Informations de publication

Date de publication:
14 05 2020
Historique:
received: 04 02 2020
accepted: 05 05 2020
entrez: 16 5 2020
pubmed: 16 5 2020
medline: 2 7 2021
Statut: epublish

Résumé

About 13 years since the introduction of antiretroviral therapy (ART) for children living with HIV (CLHIV) in Zambia, HIV/AIDS testing and treatment guidelines for children have evolved over the years with limited documentation of long-term trends in the numbers testing HIV positive and initiating ART. We examined trends in HIV testing and ART initiation in Zambia. We conducted a retrospective cohort study using routinely collected patient level data from 496 health facilities across Zambia. We used Poisson regression to derive incident rate ratios and 95% confidence intervals (95% CI) for background characteristics and used a Cuzick non-parametric test for trends to test the 13-year trends. Median time from testing to ART initiation in days and incidence rates were derived using life tables in survival analysis. We used multi-level random effects Poisson regression model to determine variations in time from HIV testing to ART initiation by facility. Overall, the cumulative proportion of the children who tested positive and initiated antiretroviral therapy (ART for HIV) from 2004 to 2017 was 69% (n = 99 592). During the period under review proportions of ART initiation increased from 52% in 2004-2006 to 97% in 2016-2017 (P < 0.001) and time from testing to ART initiation reduced from a median of 17 days IQR (1-161) in 2004 to one day IQR (1-14), P < 0.001 in 2016-2017. CLHIV were 15 times more likely to be initiated on ART in 2016-17 compared to period 2004-6 (IRR = 15.2, 95% CI 14.7-15.7). Time to ART initiation increased with age and was higher in rural health facilities compared to urban facilities. About 11% of the variability in time to ART initiation in children could be attributed to differences between facilities. The substantial increase in ART initiation and reduction in time to ART initiation among CLHIV identified in this study, reflects improvements in the paediatric HIV programme in Zambia in relation to health care delivery and adherence to national testing and treatment guidelines that were adapted from WHO guidelines. However, age-related differentials in rates of ART initiation suggests that urgent interventions are needed to sustain and further improve programme performance.

Sections du résumé

BACKGROUND
About 13 years since the introduction of antiretroviral therapy (ART) for children living with HIV (CLHIV) in Zambia, HIV/AIDS testing and treatment guidelines for children have evolved over the years with limited documentation of long-term trends in the numbers testing HIV positive and initiating ART. We examined trends in HIV testing and ART initiation in Zambia.
METHODS
We conducted a retrospective cohort study using routinely collected patient level data from 496 health facilities across Zambia. We used Poisson regression to derive incident rate ratios and 95% confidence intervals (95% CI) for background characteristics and used a Cuzick non-parametric test for trends to test the 13-year trends. Median time from testing to ART initiation in days and incidence rates were derived using life tables in survival analysis. We used multi-level random effects Poisson regression model to determine variations in time from HIV testing to ART initiation by facility.
RESULTS
Overall, the cumulative proportion of the children who tested positive and initiated antiretroviral therapy (ART for HIV) from 2004 to 2017 was 69% (n = 99 592). During the period under review proportions of ART initiation increased from 52% in 2004-2006 to 97% in 2016-2017 (P < 0.001) and time from testing to ART initiation reduced from a median of 17 days IQR (1-161) in 2004 to one day IQR (1-14), P < 0.001 in 2016-2017. CLHIV were 15 times more likely to be initiated on ART in 2016-17 compared to period 2004-6 (IRR = 15.2, 95% CI 14.7-15.7). Time to ART initiation increased with age and was higher in rural health facilities compared to urban facilities. About 11% of the variability in time to ART initiation in children could be attributed to differences between facilities.
CONCLUSIONS
The substantial increase in ART initiation and reduction in time to ART initiation among CLHIV identified in this study, reflects improvements in the paediatric HIV programme in Zambia in relation to health care delivery and adherence to national testing and treatment guidelines that were adapted from WHO guidelines. However, age-related differentials in rates of ART initiation suggests that urgent interventions are needed to sustain and further improve programme performance.

Identifiants

pubmed: 32408890
doi: 10.1186/s12981-020-00277-0
pii: 10.1186/s12981-020-00277-0
pmc: PMC7226945
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18

Références

Infect Dis Poverty. 2015 May 04;4:18
pubmed: 25954505
BMC Infect Dis. 2015 Mar 26;15:157
pubmed: 25881135
AIDS Care. 2013;25(12):1520-6
pubmed: 23528004
PLoS Med. 2010 Feb 02;7(2):e1000178
pubmed: 20126383
PLoS One. 2013 Dec 09;8(12):e81037
pubmed: 24363808
JAMA. 2006 Aug 16;296(7):782-93
pubmed: 16905784
JAMA. 2007 Oct 24;298(16):1888-99
pubmed: 17954540
PLoS One. 2017 Jan 12;12(1):e0169871
pubmed: 28081230
BMC Pediatr. 2010 Jul 30;10:54
pubmed: 20673355
J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):202-8
pubmed: 19504732
AIDS. 2009 Sep 24;23(15):2039-46
pubmed: 19684508

Auteurs

Tendai Munthali (T)

School of Public Health, University of Zambia, Lusaka, Zambia. munthalitendai@gmail.com.
Ministry of Health, Lusaka, Zambia. munthalitendai@gmail.com.

Charles Michelo (C)

School of Public Health, University of Zambia, Lusaka, Zambia.

Paul Mee (P)

Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, UK.

Crispin Moyo (C)

Equip Health, Lusaka, Zambia.

Andrew Kashoka (A)

Ministry of Health, Lusaka, Zambia.

Liswaniso Liswaniso (L)

Ministry of Health, Lusaka, Zambia.

Innocent Chiboma (I)

Ministry of Health, Lusaka, Zambia.

Jim Todd (J)

Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH